Kye Pharmaceuticals Places No. 105 on The Globe and Mail's Eighth Annual Ranking of Canada's Top Growing Companies.
Knight earned the ranking with 53% three-year revenue growth, and the full 2026 list includes 375 companies.
- On Friday, September 25, 2026, Knight Therapeutics Inc. announced it ranked on the 2026 Report on Business magazine's ranking of Canada's Top Growing Companies.
- The editorial ranking, launched in 2019, celebrates innovative businesses in Canada. To qualify for the voluntary program, companies must complete an in-depth application and fulfill revenue requirements.
- Knight earned its spot with three-year revenue growth of 53%. "This recognition belongs to our team across Canada and Latin America," said Samira Sakhia, President and CEO of Knight.
- This marks the sixth consecutive year Knight has received the designation, and the company has over 50 product launches completed or planned across its regions.
- Full editorial coverage of the 2026 winners will appear in the October issue, as Dawn Calleja, editor of Report on Business magazine, noted the ranking celebrates Canadian business resilience.
19 Articles
19 Articles
The Paintsville Herald
Kye Pharmaceuticals places No. 105 on The Globe and Mail's eighth annual ranking of Canada's Top Growing Companies.
MISSISSAUGA, ON, Sept. 25, 2026 /PRNewswire/ -- Kye Pharmaceuticals is pleased to announce it has ranked No. 105 on the 2026 Report on Business magazine's ranking of Canada's Top Growing Companies.
Knight Therapeutics Inc. places No. 345 on The Globe and Mail’s eighth annual ranking of Canada's Top Growing Companies
MONTREAL, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) ('Knight” or 'the Company”) is pleased to announce it has ranked No. 345 on the 2026 Report on...
Knight Therapeutics Inc. places No. 345 on The Globe and Mail's eighth annual ranking of Canada's Top Growing Companies
MONTREAL, Sept. 25, 2026 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX:GUD) (“Knight” or “the Company”) is pleased to announce it has ranked No. 345 on the 2026 Report on Business magazine’s ranking of Canada’s Top Growing Companies. Canada’s Top Growing Companies ranks Canadian companies on three-year revenue growth. Knight earned its spot with three-year growth […]
The Toronto Star
Knight Therapeutics Inc. places No. 345 on The Globe and Mail’s eighth annual ranking of Canada’s Top Growing Companies
MONTREAL, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX:GUD) (“Knight” or “the Company”) is pleased to announce it has ranked No. 345 on the 2026 Report on Business
Coverage Details
Bias Distribution
- 38% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
